The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels.
Saved in:
| Title: | The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels. |
|---|---|
| Authors: | Hackl B; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Lukacs P; ELKH, Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary., Ebner J; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Pesti K; Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary.; Semmelweis University, School of Ph.D. Studies, Budapest, Hungary., Haechl N; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Földi MC; ELKH, Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary.; Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary., Lilliu E; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Schicker K; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Kubista H; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Stary-Weinzinger A; Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria., Hilber K; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Mike A; ELKH, Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary.; Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary., Todt H; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria., Koenig X; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 May 02; Vol. 13, pp. 809802. Date of Electronic Publication: 2022 May 02 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35586063 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hackl+B%22">Hackl B</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Lukacs+P%22">Lukacs P</searchLink>; ELKH, Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary.<br /><searchLink fieldCode="AU" term="%22Ebner+J%22">Ebner J</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Pesti+K%22">Pesti K</searchLink>; Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary.; Semmelweis University, School of Ph.D. Studies, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Haechl+N%22">Haechl N</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Földi+MC%22">Földi MC</searchLink>; ELKH, Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary.; Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Lilliu+E%22">Lilliu E</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schicker+K%22">Schicker K</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kubista+H%22">Kubista H</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Stary-Weinzinger+A%22">Stary-Weinzinger A</searchLink>; Department of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hilber+K%22">Hilber K</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Mike+A%22">Mike A</searchLink>; ELKH, Plant Protection Institute, Centre for Agricultural Research, Martonvásár, Hungary.; Department of Biochemistry, ELTE Eötvös Loránd University, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Todt+H%22">Todt H</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Koenig+X%22">Koenig X</searchLink>; Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 May 02; Vol. 13, pp. 809802. <i>Date of Electronic Publication: </i>2022 May 02 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35586063 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2022.809802 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 809802 Titles: – TitleFull: The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hackl B – PersonEntity: Name: NameFull: Lukacs P – PersonEntity: Name: NameFull: Ebner J – PersonEntity: Name: NameFull: Pesti K – PersonEntity: Name: NameFull: Haechl N – PersonEntity: Name: NameFull: Földi MC – PersonEntity: Name: NameFull: Lilliu E – PersonEntity: Name: NameFull: Schicker K – PersonEntity: Name: NameFull: Kubista H – PersonEntity: Name: NameFull: Stary-Weinzinger A – PersonEntity: Name: NameFull: Hilber K – PersonEntity: Name: NameFull: Mike A – PersonEntity: Name: NameFull: Todt H – PersonEntity: Name: NameFull: Koenig X IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 2022 May 02 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |